Inovio Pharmaceuticals Inc (INO)

6.71 -0.33  -4.69% NASDAQ Oct 22, 14:56 USD
View Full Chart
Price Chart
View All INO News

News

View All Events

Events

Date Type Description
11/09/2021 Earnings Results Q3 2021 Earnings Results
11/09/2021 16:30 EST Earnings Calls Q3 2021 Earnings Call
08/09/2021 Earnings Results Q2 2021 Earnings Results
08/09/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
05/13/2021 11:00 EST AGM 2020 Annual General Meeting
05/10/2021 Earnings Results Q1 2021 Earnings Results
05/10/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
03/01/2021 Earnings Results Q4 2020 Earnings Results
03/01/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
11/09/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
  • URL: https://www.inovio.com
  • Investor Relations URL: https://ir.inovio.com
  • HQ State/Province: Pennsylvania
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 09, 2021
  • Last Earnings Release: Aug. 09, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
F000016ZDA ST Healthcare Innovations 11 F RE 4.25%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.